Gyre Therapeutics, Inc. (NASDAQ: GYRE)

$7.86 -0.08 (-1.01%)
As of Apr 21, 2026 03:59 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001124105
Market Cap 707.61 Mn
P/E 158.40
P/S 6.07
Div. Yield 0.00
ROIC (Qtr) 0.07
Revenue Growth (1y) (Qtr) 33.45
Add ratio to table...

About

Consolidated Entities Breakdown of Revenue (2024)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.34 Bn 28.15 9.28 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.06 Bn 17.30 5.44 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 41.92 Bn 152.39 13.31 -
4 RVMD Revolution Medicines, Inc. 28.36 Bn -25.11 34,170.56 -
5 ZLAB Zai Lab Ltd 25.77 Bn -147.06 106.30 0.20 Bn
6 MESO Mesoblast Ltd 24.32 Bn -190.54 1,414.27 0.12 Bn
7 MRNA Moderna, Inc. 21.25 Bn -7.52 10.93 0.59 Bn
8 RPRX Royalty Pharma plc 20.83 Bn 27.08 8.76 8.95 Bn